Enzalutamide Approved for Prostate Cancer With Biochemical Recurrence: Stephen Freedland, MD Published 2023-12-01 Download video MP4 360p Download video MP4 720p Recommendations 1:01:15 Prostate Cancer A Year in Review and the Year to Come 14:39 New FDA Approved PARP Inhibitor: Talzenna (Talazoparib) & Xtandi | #markscholzmd #AlexScholz #pcri 22:49 Highlights of the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD 28:12 Avoiding Unnecessary Treatment of the Small Renal Mass | Brian Shuch, MD | UCLAMDChat 06:39 PSA Recurrence: When Should You Treat? | Ask a Prostate Expert, Mark Scholz, MD 10:22 What is it like having Prostate Radiotherapy treatment? 1:28:26 Cancer Metabolism: From molecules to medicine 15:51 Introduction to Immunotherapy (Immunotherapy Documentary Part I) 21:50 Treating Micro-Metastatic #ProstateCancer Disease | #MarkScholzMD #AlexScholz #PCRI 30:35 Fetal Cardiac Screening: How to Improve CHD Detection | Mark Sklansky, MD | UCLAMDChat 05:51 Plan B: Salvage Treatment for Prostate Cancer 12:21 Top 10 Highest Paying Healthcare Jobs 1:10:35 Prostate Cancer Treatment Options | Online Health Talk 2023 16:53 Bone Metastasis: Diagnosis and Scans | #MarkScholzMD #AlexScholz #PCRI 48:32 A future with No Prostate Biopsies with Mark Emberton, MD EP 86 06:00 7 Things to Know About Prostate Cancer with Radiation Oncologist Florence Wright, MD 1:12:13 Advanced #ProstateCancer Treatments | Eugene Kwon, MD | DIY Combat Manual | Part 5 #PCRI 10:04 Understanding PSA, PIRADS, Tumor Size, & Location | Answering YouTube Comments #59 | Mark Scholz, MD 21:07 Are Newer #ProstateCancer Treatments Better? | #MarkScholzMD #AlexScholz #PCRI 1:32:16 An Answer to Cancer? Using the immune system to fight cancer -- Longwood Seminar Similar videos 09:32 EMBARK: Changing the Landscape in High-Risk BCR Prostate Cancer 09:07 EMBARK: Implications for Treating Patients With High-Risk BCR Prostate Cancer in Your Practice 02:00 Freedland: Early ADT After Recurrence Following RP 01:40 Evaluating Significance of ENZAMET Trial in Metastatic Hormone-Sensitive Prostate Cancer 31:24 Optimizing androgen deprivation therapy (ADT) in advanced prostate cancer 19:24 M0 CRPC: Treatment Options and Emerging Concepts 18:22 Manipulating the Androgen Axis 07:13 What is the Difference Between Clinical and Pathologic Staging for Prostate Cancer? 09:46 Treating High-Risk Localized Prostate Cancer 2:00:13 4/3/2023 - Hi-Risk/Recurrent/Advanced PCa Men & Caregiver 39:45 Toni's Top 10 GU Oncology Papers 2023!! 25:45 Summarizing the RADAR Guidelines 20:17 RADAR III: Next Generation Imaging 59:28 What You Need to Know About Oral ADT - Summit 2021 More results